XAIR
Beyond Air, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website beyondair.net
- Employees(FY) 98
- ISIN US08862L1035
Performance
-0.55%
1W
+46.22%
1M
-4.36%
3M
-64.12%
6M
-74.92%
YTD
-69.08%
1Y
Profile
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Technical Analysis of XAIR 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-14 03:05
- 2024-11-11 03:05
- 2024-11-10 18:00
- 2024-11-07 18:06
- 2024-10-29 04:22
- 2024-10-06 19:00
- 2024-10-01 19:30
- 2024-09-27 19:40
Beyond Air to sell 40.39M shares at 51c in private placement(Yahoo Finance)
- 2024-09-27 19:35
- 2024-09-26 19:34
- 2024-09-26 19:32
- 2024-09-26 19:30
- 2024-09-22 20:00
- 2024-08-06 04:05
- 2024-07-31 04:15
- 2024-07-23 04:05
- 2024-07-16 04:05
- 2024-07-09 21:55
- 2024-06-25 20:01
- 2024-06-24 22:31
- 2024-06-24 20:28
Why Is Beyond Air (XAIR) Stock Down 22% Today?(Investorplace)
- 2024-06-24 19:37
- 2024-06-24 08:53
- 2024-06-24 05:25
- 2024-06-24 04:15
- 2024-06-13 04:05
- 2024-06-02 19:00
- 2024-05-23 04:09
- 2024-04-30 19:00
- 2024-03-21 00:00
Page 1 of 5
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.